Boston Seminar Series: Latest Developments in Post-Grant Proceedings for Biosimilars

Tuesday April 5, 2016
12:00 PM– 1:30 PM at theCatalyst Restaurant

Fish Principals Dorothy Whelan and Teresa Lavoiepresented at ourBoston Seminar Series lunch with a discussion inter partes review (IPR) as an alternative option for resolving patent-related disputes involving biosimilars. As the number of biopharma petitions continues to rise at the Patent Trial and Appeal Board, there are strategic issues related to post-grant practice and biosimilars that life sciences companies must consider. Dorothy and Teresa sharedtheir views on the latest developments, including:

• A review of biosimilars IPR filings and PTAB decisions to date;
• Multiple filer/multiple petitions issues and related timing considerations;
• Tips for both challengers and patent owners.

To download the PDF presentation, click here.